Did You Know...
...that the video game, Pong, was invented by a guy who graduated at the bottom of his engineering class? Nolan Bushnell spent more time running the games at a local amusement park than he did on his studies at the University of Utah. His dreams of working for Disney's amusement empire were dashed when the company wouldn't hire him. Taking a boring job, Nolan daydreamed about electronic versions of popular games. He invented Pong, the first video game, and went on to found Atari Co.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7915291 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising... | 03/29/2011 |
| 7772183 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed. ... | 08/10/2010 |
| 7741281 | Hepatitis C virus inhibitors Macrocyclic peptides are disclosed having the general formula: wherein R′, R3, R3′, R4, R6, X, Q, and W are described. Compositions comprising the com... | 06/22/2010 |
| 7449479 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds an... | 11/11/2008 |
| 7309708 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds... | 12/18/2007 |
| 7135462 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors are disclosed having the general formula: wherein A, R2, R3, R′, B and Y are described in the description. Compositions comprising the... | 11/14/2006 |
| 7135465 | Sustained release beadlets containing stavudine Extended dosage forms of stavudine are provided comprising beadlets formed by extrusion-spheronization and coated with a seal coating. The beadlets are also coated with a modified release coating such that a hard gelatin capsule containing such beadlets will provide... | 11/14/2006 |
| 7135467 | HIV integrase inhibitors Compounds useful for treating HIV are disclosed having the general formula wherein R1, R2, and B are as defined in the specification. Compositions containing the compounds and methods for us... | 11/14/2006 |
| 7132504 | Hepatitis C virus inhibitors Compounds are disclosed having the general formula: wherein R1, R2, R3, R4, R′, B, Y and X are described in the description. Compositions com... | 11/07/2006 |
| 7083973 | Stereoselective reduction of substituted oxo-butanes The present invention relates to a process for the stereoselective enzymatic reduction of 1-halo-2-oxo-3-(protected)amino-4-substituted-butanes utilizing certain species of Rhodococcus and Brevibacterium. The product 1-halo-2-hydroxy-3-(protected)amino... | 08/01/2006 |
| 7034152 | Process for preparing the antiviral agent [1S-(1alpha,3 alpha,4beta )]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one Processes are disclosed for preparing the antiviral agent entecavir. A resin adsorption process for the isolation and purification of entecavir is also disclosed. Various intermediates useful in the preparation of entecavir are also disclosed. ... | 04/25/2006 |
| 6995174 | Hepatitis C virus inhibitors Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Composit... | 02/07/2006 |
| 6878722 | Substituted cycloalkyl P1′ hepatitis C virus inhibitors The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and me... | 04/12/2005 |
| 6869590 | Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque Detectably labeled macrophage scavenger receptor antagonists useful for the diagnosis and monitoring of various cardiovascular diseases including but not limited to atherosclerosis, vulnerable plaque, coronary artery disease, renal disease, thrombosis, transient isc... | 03/22/2005 |
| 6869964 | Heterocyclicsulfonamide hepatitis C virus inhibitors The present invention relates to tripeptide compounds, compositions containing such compounds and methods for using such compounds for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmac... | 03/22/2005 |
| 6818201 | Vitronectin receptor antagonist pharmaceuticals The present invention describes novel compounds of the formula: (Q)d—Ln—Ch, useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of treating cancer in a patien... | 11/16/2004 |
| 6803374 | Compounds useful for treating hepatitis C virus A series of compounds of Formula I are disclosed which are useful in treating viral hepatitus C. ... | 10/12/2004 |
| 6800273 | Pharmaceuticals for the imaging of angiogenic disorders The present invention describes novel compounds of the formula: (Q)d—Ln—Ch, useful for the diagnosis and treatment of cancer, methods of imaging tumors in a patient, and methods of treating cancer ... | 10/05/2004 |
| 6777440 | HIV integrase inhibitors The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the following formula, or a tautomer of said compound, or a pharmaceutically acceptable salt, solvate or prodrug thereof: ... | 08/17/2004 |
| 6776977 | Polypodal chelants for metallopharmaceuticals Tripodal polyaminophosphonate chelants are disclosed, as well as chelates of the chelants with metal ions to form radiopharmaceutical and radioactive, MRI and X-ray or CT imaging compounds and compositions. Therapeutic and imaging methods of use are also disclosed. | 08/17/2004 |
| 6773696 | Contrast agent comprising low density microspheres Low density microspheres, methods for preparing same, and use of same as contrast agents are described. The microspheres have a void having a volume that comprises at least about 75% of the total volume of the microspheres, and which contains a gas or the vapor of a... | 08/10/2004 |
| 6770259 | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation The present invention provides novel diagnostic compositions comprising a radiolabeled LTB4 binding agent and a radiolabeled perfusion imaging agent, diagnostic kits comprising such compositions, and methods of concurrent imaging in a mammal comprising administering... | 08/03/2004 |
| 6620799 | Water soluble prodrugs of azole compounds Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided. More particularly, new water-soluble triazole antifungal compounds are provided having the general formula ##STR1## wherein A is the no... | 09/16/2003 |
| 6620934 | Water soluble prodrugs of azole compounds Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided. More particularly, new water-soluble triazole antifungal compounds are provided having the general formula ##STR1## wherein A is the no... | 09/16/2003 |
| 6589955 | Pediatric formulation of gatifloxacin There is provided in accordance with the present invention the quinolone antibacterial gatifloxacin adequately taste-masked so that it can be utilized for pediatric formulations. A crystalline co-precipitate of gatifloxacin and one or both of stearic acid... | 07/08/2003 |
| 6521783 | Processes for preparing oxygenates This invention relates in part to a processes for the conversion of a feedstock stream comprising carbon monoxide and hydrogen to a product stream comprising at least one of an ester, acid, acid anhydride and mixtures thereof. This invention also relates ... | 02/18/2003 |
| 6369283 | Processes for producing unsaturated alcohols This invention relates in part to processes for producing one or more substituted or unsubstituted unsaturated alcohols which comprise reacting one or more substituted or unsubstituted alkadienes with carbon monoxide and hydrogen in the presence of a meta... | 04/09/2002 |
| 6310260 | Separation processes This invention relates to a process for separating one or more organophosphorus ligand degradation products, one or more reaction byproducts and one or more products from a continuously generated reaction product fluid comprising one or more unreacted rea... | 10/30/2001 |
| 6307110 | Separation processes This invention relates to a process for separating one or more organophosphorus ligand degradation products, one or more reaction byproducts and one or more products from a continuously generated reaction product fluid comprising one or more unreacted rea... | 10/23/2001 |
| 6307108 | Metal-ligand complex catalyzed processes This invention relates to a process for separating one or more organophosphorus ligand degradation products, one or more reaction byproducts and one or more formylester products from a reaction product fluid comprising one or more unreacted unsaturated es... | 10/23/2001 |
| 6303830 | Metal-ligand complex catalyzed processes This invention relates to a process for separating one or more organophosphorus ligand degradation products, one or more reaction byproducts and one or more formylester products from a reaction product fluid comprising one or more unreacted unsaturated es... | 10/16/2001 |
| 6300496 | Processes for producing epsilon caprolactams This invention relates in part to processes for producing one or more substituted or unsubstituted epsilon caprolactams, e.g., epsilon caprolactam, which comprise (a) converting one or more substituted or unsubstituted hydroxyaldehydes, e.g., 6-hydroxyhex... | 10/09/2001 |
| 5413775 | Hairsprays and acrylic polymer compositions for use therein Aqueous, anionic, acrylic polymer compositions comprising a copolymer of an alkyl acrylate, an alkyl methacrylate and one or more acrylate acids or salts thereof is disclosed. By controlling the particle size of the copolymer and introducing a surfactant,... | 05/09/1995 |
| 5401803 | Ethylene-vinyl acetate copolymer additives for molding compositions Additive compositions comprising ethylene-vinyl acetate copolymers suitable for use in molding compositions are disclosed. The ethylene-vinyl acetate copolymers have a low degree of crystallinity which can provide a desirable balance of pigmentability, sh... | 03/28/1995 |
| 5139813 | Method for inducing fluorescence in parylene films by an active plasma A method is provided for inducing fluorescence in films or coatings comprised in whole or in part of parylene which involves exposure of the parylene to an active plasma. A method is also provided which utilizes plasma induced fluorescence as a means for ... | 08/18/1992 |
| 5138043 | Alkoxylated alkyl glucoside ether quaternaries useful in personal care Alkoxylated alkyl glucosides having quaternary nitrogen-containing ether substituents possess cationics utility combined with extreme mildness to skin and hair along with stable personal care compositions and processes.... | 08/11/1992 |
| 5110903 | Process for the preparation of mixed parylene dimers free of alpha-halogens A process is provided for the preparation of a mixture of parylene dimers wherein the distribution of dimers within the mixture is predetermined by the proper selection of halogenated and non-halogenated 2,2-paracyclophane starting material. Since the dim... | 05/05/1992 |
| 4861938 | Chemical conversion process A process for converting a feedstock containing 1 to about 6 carbon atoms per molecule which includes (a) contacting the feedstock with a solid composition comprising a crystalline microporous three dimensional solid catalyst having pores and being capabl... | 08/29/1989 |
| 4849575 | Production of olefins A process for producing olefins comprising: (a) contacting hydrogen and at least one carbon oxide in a first reaction zone at conditions effective to chemically react the hydrogen and carbon oxide and produce at least one product, e.g., methanol, in the efflue... | 07/18/1989 |
| 4840777 | Process for inhibiting mono and diethanolamine degradation A process for the purification of a gas stream containing impurities comprising (i) passing the gas stream through an aqueous solution of stabilized monoethanolamine or diethanolamine in such a manner that the impurities are absorbed into the monoethanola... | 06/20/1989 |
